|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Dynamic ordering for a parallel bloek- Jacobi SVD algorithm 显示文摘 | Becka M Oksa G Vajtersic M | 2002 | Parallel Computing2002，28，： | 1 |
| 2 | Safety, pharmaco- dynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor X a inhibitor--after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，： | 1 |
| 3 | Safety, pharma- codynamics, and pharmacokinetics of BAY 59-7939 an o- ral, direct factor X a inhibitor - after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 4 | Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939-an oral, direct Factor Xa inhibitor-after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 5 | Safety, pharmacodynam- ics, and pharmacokinetics of BAY 59 - 7939 - an oral, direct fac tor X ainhibitor - after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 6 | Safety,pharmaodynamics,and pharmacokinetics of BAY 59-7939 an oral,direct factor Xa inhibitor after multiple dosing in healthy male subjects显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharm acol2005，61，12： | 1 |
| 7 | Safety, pharmacodynam ies, and pharmacokinetics of BAY 59-7939-an oral, direct Factor X a inhibitor-after multiple dosing in healthy male sub- jeers 显示文摘 | Kubilza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 8 | Safety pharmacodynamics and pharmacokinetics of BAY 59-7939:an oral,direct actor Xa inhibitor:after multiple dosing in healthy male subjects显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 9 | Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939-an oral direct factor Xa inhibitor-after muhiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，： | 1 |
| 10 | Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939-an oral, direct factor Xa inhibitor-after multiple dosing in healthy male subjects显示文摘 | KUBITZA D BECKA M WENSING G | 2005 | Eur J Clin Pharmaeol2005，61，12： | 1 |
| 11 | On iterative QR pre-processing in the parallel block-jacobi SVD algorithm显示文摘 | Becka M Oksa G Vajtersic M | 2009 | Parallel Computing2009，36，6： | 1 |
| 12 | Safety, pharmacodynamics and pharmacokinetics of BAY 59-7939-an oral, direct Factor Xa inhibitor-after multiple dosing ha healthy male subjects显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Phannacol2005，61，12： | 1 |
| 13 | Safety, pharmacody- namics, and pharmaeokineties of BAY 59-7939-an oral, di- rect Factor Xa inhibitor--after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 14 | Safety, pharmacodynamics, and pharma-cokinetics of BAY 59 - 7939 - anoral, direct factor Xa in- hibitor - after multiple dosing inhealthy male subjects 显示文摘 | Kibbitz D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 15 | Salty, pharmacodynamics, and pharmacokinetics of BAY 59 -1939: an oral,direct Factor Xa in hibitor: after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmaco12005，61，12： | 1 |
| 16 | Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939-an oral, direct Factor Ⅹa inhibitor-after multiple dosing in healthy male subjects显示文摘 | KUBITZA D BECKA M WENSING G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 17 | Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939-an oral, direct factor Xa inhibitor-after multiple dosing in healthy male subjects显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 18 | High temperature lead-free solder for microelectronics显示文摘 | Becka G | 2001 | JOM2001，6，： | 1 |
| 19 | Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939 -- an oral, direct Factor Xa inhibitor-after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 20 | Safety,pharmacodynamics,and pharmacokinetics of BAY 59-7939-an oral,direct factor Ⅹa inhibitor-after multiple dosing in healthy male subjects显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员